William McGee

William T. McGee is a professor of Medicine, Surgery and Anesthesiology at the University of Massachusetts Medical School and a specialist in critical care medicine with interests in hemodynamic physiology, trauma, brain injury, ARDS, vascular access (pulmonary artery catheterization), sepsis, and nosocomial pneumonia. Dr. McGee has published over 150 papers, chapters and abstracts and has been the principal investigator for clinical trials evaluating the efficacy and safety of new treatments for severe sepsis, MRSA and pneumonia. Presently his primary focus is on functional hemodynamics, physiologic optimization and the safety of central venous access. Dr. McGee was the lead enroller and author on the paper that reported the outcome of linezolid versus vancomycin for the treatment of MRSA pneumonia. Early in his career he was a finalist for the Cecil Lehman Mayer Research Award from the American College of Chest Physicians for his work examining the utility of pulmonary artery catheterization in the critically ill. He was awarded the Internal Medicine Specialty Award at the Society’s 29th Scientific Symposium for research published in the Journal of American Medical Association. [Patient characteristics and ICU organizational factors that influence frequency of pulmonary artery catheterization JAMA 2000; 283:2559.] Dr. McGee developed the “Physiologic Optimization Program” and has published several papers on its use and care of the critically ill. [J Inten Care med 2009; Nov-Dec 24(6):352.] His copyrighted algorithm described in these papers has been distributed world-wide in 11 different languages. He is the editor of the Quick Guide to Cardiopulmonary Care published by Edwards Critical Care Education and widely used throughout the world. His research on the safe length of central venous catheters has made this, procedure safer for millions of patients.